During the time of observation, PyV MT/jnk2−/− mice developed palpable tumors earlier than the PyV MT/jnk2+/+ mice (median time to first tumor palpation, T50 = day 55 vs. day 70, respectively). The gene discussed is MAPK9; the disease is neoplasm.